The Patent Finder

Alfasigma S.P.A.

Also on record
Records under this name other than the patents Alfasigma S.P.A. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 82 patents it holds.

Back to Alfasigma S.P.A.

PatentTitleStatus Expires Confidence
US 11,464,814Topical Composition for Use in the Treatment of Inflammatory Bowel Disease
Lapsed on the fee record
Ended Oct 11, 2026 · High confidence
Lapsed on the fee recordEnded Oct 11, 2026High confidence
US 11,433,043Compounds Useful for Increasing Neurogenesis in Neural Tissue
Lapsed on the fee record
Ended Sep 6, 2026 · High confidence
Lapsed on the fee recordEnded Sep 6, 2026High confidence
US 7,375,114Quinolinone-Carboxamide Compounds as 5-HT4 Receptor Agonists
Term ended
Ended no later than Jul 27, 2026 · Medium confidence
Term endedEnded no later than Jul 27, 2026Medium confidence
US 10,285,944Gastroresistant pharmaceutical formulations containing rifaximin
Term ended
Term ended Jul 16, 2026 · From the USPTO record
Term endedTerm ended Jul 16, 2026From the USPTO record
US 8,758,835Composition useful for the prevention or reduction of the progression of prostate cancer
Lapsed on the fee record
Ended Jun 24, 2026 · From the USPTO record
Lapsed on the fee recordEnded Jun 24, 2026From the USPTO record
US 7,728,006Quinolinone-carboxamide compounds as 5-HT4 receptor agonists
Term ended
Term ended Jun 12, 2026 · From the USPTO record
Term endedTerm ended Jun 12, 2026From the USPTO record
US 8,748,447Rifaximin powder, process for preparing the same and controlled release compositions containing said rifaximin useful for obtaining a long-lasting effect
Lapsed on the fee record
Ended Jun 10, 2026 · From the USPTO record
Lapsed on the fee recordEnded Jun 10, 2026From the USPTO record
US 8,748,449Use of polyols to obtain stable polymorphous forms of rifaximin
Lapsed on the fee record
Ended Jun 10, 2026 · From the USPTO record
Lapsed on the fee recordEnded Jun 10, 2026From the USPTO record
US 9,126,994Crystalline form of a quinolinone-carboxamide compound
Term ended
Term ended Apr 5, 2026 · From the USPTO record
Term endedTerm ended Apr 5, 2026From the USPTO record
US 9,402,840Crystalline form of a quinolinone-carboxamide compound
Term ended
Term ended Apr 5, 2026 · From the USPTO record
Term endedTerm ended Apr 5, 2026From the USPTO record
10 of 81 patents shown.
Pro members see all 81.
Pro members: see all 81 patents
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited